startup series
a better diagnostic tool for
TB, Manikankana mentions,
“Tuberculosis is killing people
every day throughout the world.
According to a WHO report
prepared in 2015, India is amongst
the top 30 high burden countries.
One of the problems was found
to be “missed-out” cases during
detection,” she continues, “So with
our novel and simple technology,
as developed through research, we
wanted to help suspected missed-
out cases of TB.”
Slow yet steady towards the goal
Over the past two years,
38
BioVoiceNews | September 2017
Annweshan has generated data
on approximately 1800+ samples,
going beyond what was required
for their BIG project. The primary
focus at this moment is the second
phase of data generation, which is
critical to the validation process and
in line with the requirements for
the successful commercialization of
their disease detection kit.
However, it wasn’t all smooth
sailing for the company to get to
where it is today. The company
was founded in 2015 under the
Lab2Market program of Venture
Center with the BIG grant from
DBT-BIRAC and assistance from